JP Patent

JP6644328B2 — アトピー性疾患の発症又は重症化リスクの評価法

Assigned to Rohto Pharmaceutical Co Ltd · Expires 2020-02-12 · 6y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: JP6644328B2
Jurisdiction: JP
Classification: —
Expires: 2020-02-12
Drug substance claim: No
Drug product claim: No
Assignee: Rohto Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.